Inflammatory Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2022-10-28
EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
EMA recommends measures to minimize serious side effects associated with Janus kinase inhibitors used for chronic inflammatory disorders.